We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Need for Additional Imaging in PET/CT Oncologic Reports Reexamined

By HospiMedica International staff writers
Posted on 28 May 2012
Radiologists and nuclear medicine physicians recommended additional imaging approximately 30% of the time in oncologic positron emission/computed tomography (PET/CT) reports, with about half of those recommendations being unnecessary, a new study shows. More...


The study, conducted at Brigham and Women’s Hospital (Boston, MA, USA), included 250 patients. The study’s findings revealed that there were 84 recommendations made for additional imaging. When study reviewers studied the patients’ records, they concluded that 43 of those recommendations were unnecessary, according to Atul Shinagare, MD, one of the authors of the study. No adverse patient outcome would have occurred by not recommending further imaging tests in these 43 cases, according to Dr. Shinagare.

The study did not particularly address the motivating factors behind the recommendations for additional imaging, however, “we feel that some of the most important factors leading to unnecessary recommendations include reluctance of physicians to accept uncertainty regarding diagnosis, partly driven by medicolegal concerns combined with a failure to fully consider the patients’ clinical circumstances, and the likely cost-effectiveness of additional imaging tests,” said Dr. Shinagare.

The study also found that 70% of the time, referring physicians did not follow through on the radiologists’ recommendation for additional imaging. Radiologists and nuclear medicine physicians may not have access to the complete medical history of patients referred for PET/CT imaging, according to Dr. Shinagare. “On the other hand, ordering clinicians usually know the patient record and history, which may put them in a better position to judge the necessity of some recommended additional imaging,” Dr. Shinagare said.

The study was presented May 8, 2012, at the American Roentgen Ray Society annual meeting held in Vancouver (BC, Canada).

Related Links:
Brigham and Women’s Hospital


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Spirometry & Oximetry Software
MIR Spiro
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.